Treatment of Hodgkin's Lymphoma During Pregnancy
Hodgkin lymphoma (HL) is among the most common cancers diagnosed during pregnancy. Managing it requires careful consideration of the gestational stage at diagnosis, disease severity, and the safety of the mother and baby.
Clinical Scenario
This protocol addresses pregnant patients who receive a new diagnosis of Hodgkin lymphoma. Because HL primarily affects adolescents and young adults, it is one of the most common types of cancer diagnosed during pregnancy.
Treatment decisions depend on several factors: the trimester at time of diagnosis, the stage and aggressiveness of the disease, and whether the patient has significant symptoms.
Approach to Treatment
When possible, treatment is deferred until after the first trimester. Combination chemotherapy given later in pregnancy has a role in this setting. In certain situations during the second and third trimesters, a watchful-waiting strategy may also be considered.
Full sequencing, eligibility criteria, and regimen details are available in the structured protocol →
References
- Because HL primarily affects adolescents and young adults, it is one of the most common types of cancer diagnosed during pregnancy.
- If a person is pregnant when diagnosed with HL, the treatment options depend on several factors, including: the trimester at the time of diagnosis; the stage and aggressiveness of the disease; and whether or not the patient has significant symptoms.
- If possible, treatment should be delayed until at least the second trimester (the second 3 months) of pregnancy, because the risks of treatment to the fetus are greatest during the first trimester.
- Combination chemotherapy regimens given after the first trimester appear to be safe for both the mother and the baby.
- For patients in their second and third trimesters, doctors may consider delaying treatment until after delivery of the baby (watchful waiting), if they determine that a delay in therapy would not impair the mother's health.
View source ↗